Skip to main content
TOPICS
Videos
Provider
Payer
Pharma
Consumer
Investor
RESOURCES
Events
Jobs
Learning Center
Webinars
White Papers
REGIONS
ANZ
ASIA
EMEA
Global Edition
MORE
About
Advertise
Contact
Privacy Policy
ANZ
ASIA
EMEA
Global Edition
RenalytixAI
AI-powered kidney disease diagnostic Renalytix AI lands $29M
By
Laura Lovett
|
02:40 pm |
November 19, 2018
This latest funding news coincides with the company's announcement that it will now be publicly traded on the London Stock Exchange.